Forty-nine states sued 20 manufacturers of generic drugs, alleging an anticompetitive scheme to “fix, maintain, and stabilize prices, rig bids, and engage in market and customer allocations” of certain generic … Continue reading Court Affirms States’ Parens Patriae Standing in Antitrust Case